[INM] YoY Quarter Result on 30-Jun-2023 [#Q4]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
21-Dec-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q4]
Profit Trend
QoQ- 83.08%
YoY- 95.71%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 1,283 2,311 515 0 0 0 0 -
PBT -1,931 -337 -7,870 -3,259 -1,951 -3,367 -2,226 -2.33%
Tax 7 2 -34 10 271 -27 -45 -
NP -1,938 -338 -7,870 -3,259 -1,951 -3,367 -2,226 -2.28%
Tax Rate - - - - - - - -
Total Cost 3,221 2,649 8,385 3,259 1,951 3,367 2,226 6.34%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -151.02 -14.64 -1,528.88 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.22 -0.10 -12.22 -10.13 -9.32 -16.08 -11.72 -48.41%
EPS Diluted -0.22 -0.10 -12.22 -10.13 -9.32 -16.08 -11.72 -48.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.